Wegovy®️ pill demonstrated greater weight loss than orforglipron and lower odds of stopping medication due to side effects in a new indirect comparison presented at Obesity Medicine Association 2026
Oral semaglutide 25 mg demonstrated significantly greater mean weight loss than orforglipron 36 mg in a population-adjusted indirect treatment comparison (ITC) using data from the OASIS 4 and ATTAIN-1 clinical…











